Javascript must be enabled to continue!
Pulmonary carcinoid: own experience of surgical treatment
View through CrossRef
Objective. To share own experience for surgical treatment of pulmonary carcinoid tumours.
Materials and methods. During last 13 yrs in Department of Thoracic Surgery and Invasive Methods of Diagnosis of Yanovskyi National Institute of Phthisiatry and Pulmonology were treated 45 patients, suffering pulmonary carcinoid. Average age of the patients have constituted 45 yrs old. Among the patients the women prevailed – 31 (68.9%). Concomitant pathology have had 15.6% patients. In 38 (84.4%) patients the disease was diagnosed accidentally in elective roentgenological examination. Pronounced clinical features of the disease were observed in 3 (6.7%) patients only. Additional 4 (8.9%) patients complained about insignificant worsening in general well-being: moderate dyspnea, dry periodical cough, frequent bronchitis.
Results. There were 44 (97.8%) patients operated. The most frequent operation performed in patients with pulmonary carcinoid was lobectomy in various modifications: a classic one – in 16 (36.4%), video-assisted – 13 (29.5%), and bronchoplastic – 5 (11.4%). Operative interventions were performed in accordance to rules for thoracic surgery and for oncological surgery in particular. In a central localization of the process the diagnosis was verified preoperatively in all the patients, while in peripheral carcinoids only - in 2 (25.0%) patients, in whom transthoracic biopsy with histological investigation of biopsies was performed. In other 6 (75.0%) patients, suffering peripheral carcinoid, intraoperative histological or cytological investigations with determination of further surgical tactics were conducted.
Conclusion. Pulmonary carcinoid is characterised by slow course and absence of pronounced clinical signs, what causes its late diagnosis. To select an optimal method of surgical treatment histological verification of the diagnosis is mandatory. In treatment of pulmonary carcinoid tumours, surgical method is choosed.
Title: Pulmonary carcinoid: own experience of surgical treatment
Description:
Objective.
To share own experience for surgical treatment of pulmonary carcinoid tumours.
Materials and methods.
During last 13 yrs in Department of Thoracic Surgery and Invasive Methods of Diagnosis of Yanovskyi National Institute of Phthisiatry and Pulmonology were treated 45 patients, suffering pulmonary carcinoid.
Average age of the patients have constituted 45 yrs old.
Among the patients the women prevailed – 31 (68.
9%).
Concomitant pathology have had 15.
6% patients.
In 38 (84.
4%) patients the disease was diagnosed accidentally in elective roentgenological examination.
Pronounced clinical features of the disease were observed in 3 (6.
7%) patients only.
Additional 4 (8.
9%) patients complained about insignificant worsening in general well-being: moderate dyspnea, dry periodical cough, frequent bronchitis.
Results.
There were 44 (97.
8%) patients operated.
The most frequent operation performed in patients with pulmonary carcinoid was lobectomy in various modifications: a classic one – in 16 (36.
4%), video-assisted – 13 (29.
5%), and bronchoplastic – 5 (11.
4%).
Operative interventions were performed in accordance to rules for thoracic surgery and for oncological surgery in particular.
In a central localization of the process the diagnosis was verified preoperatively in all the patients, while in peripheral carcinoids only - in 2 (25.
0%) patients, in whom transthoracic biopsy with histological investigation of biopsies was performed.
In other 6 (75.
0%) patients, suffering peripheral carcinoid, intraoperative histological or cytological investigations with determination of further surgical tactics were conducted.
Conclusion.
Pulmonary carcinoid is characterised by slow course and absence of pronounced clinical signs, what causes its late diagnosis.
To select an optimal method of surgical treatment histological verification of the diagnosis is mandatory.
In treatment of pulmonary carcinoid tumours, surgical method is choosed.
Related Results
Hydatid Disease of The Brain Parenchyma: A Systematic Review
Hydatid Disease of The Brain Parenchyma: A Systematic Review
Abstarct
Introduction
Isolated brain hydatid disease (BHD) is an extremely rare form of echinococcosis. A prompt and timely diagnosis is a crucial step in disease management. This ...
Pulmonary carcinoid tumours
Pulmonary carcinoid tumours
Key pointsPulmonary carcinoid tumours account for 2% of all lung tumours, with an increase in incidence due to more accurate diagnostic techniques.Carcinoid tumours are relatively ...
Analysis of ErbB Receptors in Pulmonary Carcinoid Tumors
Analysis of ErbB Receptors in Pulmonary Carcinoid Tumors
AbstractPurpose: This study aimed to investigate the expression of the ErbB family of receptor tyrosine kinases in pulmonary typical carcinoid and atypical carcinoid tumors and to ...
Incidental Presentation of Carcinoid Tumor
Incidental Presentation of Carcinoid Tumor
Abstract
Introduction: Carcinoid tumors are a group of neuroendocrine tumors (NETs) that originate in the gastrointestinal tract, lungs, adrenal glands, thyroid o...
Surgical treatment for bronchopulmonary carcinoid
Surgical treatment for bronchopulmonary carcinoid
Surgical treatment was performed in 286 patients with lung cancer. The final morphological study diagnosed typical and atypical carcinoid tumors in 258 (90.2%) and 28 (9.8%) patien...
Past Cases, Present Insights: Surgical Outcomes of Pulmonary Carcinoid Tumours - An Institutional Experience
Past Cases, Present Insights: Surgical Outcomes of Pulmonary Carcinoid Tumours - An Institutional Experience
Background and ObjectivesPulmonary carcinoid tumours are rare, representing 1-2% of all lung cancers. Surgical resection offers curative-intent treatment with 5-year survival rates...
P221 Carcinoid heart disease
P221 Carcinoid heart disease
Abstract
Carcinoid heart disease is a rare disease, which develops in 20-50% of patients with carcinoid syndrome and is a main predictor of clinical outcome in those...
Data from Pathways Impacted by Genomic Alterations in Pulmonary Carcinoid Tumors
Data from Pathways Impacted by Genomic Alterations in Pulmonary Carcinoid Tumors
<div>Abstract<p><b>Purpose:</b> Pulmonary carcinoid tumors account for up to 5% of all lung malignancies in adults, comprise 30% of all carcinoid malignanci...

